Non-competitive immunochemiluminometric assay for cardiotrophin-I detects elevated plasma levels in human heart failure

Clinical Science

Volumn 102, Issue 4, 2002, Pages 411-416

  Ng, Leong L ^a   O'Brien, Russell J ^a   Demme, Bettina ^a   Jennings, Sonja ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cytokines; Growth factors; Heart failure; Hypertrophy; Immunology

Indexed keywords

ACRIDINE DERIVATIVE; AMINO ACID; CARDIOTROPHIN 1; IMMOBILIZED ANTIBODY; STREPTAVIDIN;

ADULT; ARTICLE; ASSAY; BIOTINYLATION; CARBOXY TERMINAL SEQUENCE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMOBILIZATION; IMMUNOCHEMISTRY; MALE; MEASUREMENT; PRIORITY JOURNAL;

BLOTTING, WESTERN; CHEMILUMINESCENT MEASUREMENTS; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 0036208226     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010265     Document Type: Article

References (15)

1. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways
2. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex
3. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: An autocrine loop for hypertrophy
4. Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning
5. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation
6. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
7. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli
8. An immunoluminometric assay for cardiotrophin-1: A newly identified cytokine is present in normal human plasma and is increased in heart failure
9. The heart is a source of circulating cardiotrophin-1 in humans
10. Immunoassays using acridinium esters
11. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat
12. Augmented cardiac cardiotrophin-1 in experimental congestive heart failure
13. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
14. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction
15. Measurement and significance of circulating natriuretic peptides in cardiovascular disease